# Population Effectiveness of Dolutegravir Implementation in Sub-Saharan Africa

> **NCT04066036** · — · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 1000 (actual)

## Conditions studied

- HIV-1-infection

## Interventions

- **OTHER:** This is an observational study only.

## Key facts

- **NCT ID:** NCT04066036
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-05-14
- **Primary completion:** 2023-05-31
- **Final completion:** 2023-05-31
- **Target enrollment:** 1000 (ACTUAL)
- **Last updated:** 2023-10-23

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04066036

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04066036, "Population Effectiveness of Dolutegravir Implementation in Sub-Saharan Africa". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04066036. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*